Compare Dover Corp (DOV) vs Hims and Hers Health Inc (HIMS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Dover Corp vs Hims and Hers Health Inc — how do they compare? Dover Corp trades at $188.83 (market cap $25.45B), while Hims and Hers Health Inc trades at $30.92 (market cap $6.55B). The key difference: Dover Corp is far larger — about 3.9× Hims and Hers Health Inc's market cap, and Dover Corp pays a 1.11% dividend while Hims and Hers Health Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Dover Corp for 73 Days and Hims and Hers Health Inc for 21 Days on average.
| DOV | HIMS | |
|---|---|---|
Market Cap | $25.45B | $6.55B |
Volume | 661,758 | 14,842,814 |
Sector | Industrials | Health |
52-Week High | $233.31 | $62.76 |
52-Week Low | $161.16 | $14.52 |
Typical Hold Time | 73 Days | 21 Days |
Enterprise Value | $26.95B | $7.25B |
Dividend Yield | 1.11% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Dover Corporation (DOV) trades at $188.96, showing modest daily gains of 0.36%. The stock maintains strong fundamentals with consistent earnings beats and a 67.86% analyst buy rating. Recent acquisitions and product launches demonstrate growth initiatives, while technical indicators signal near-term bearish pressure with support at $186. The company's 13.48% net margin and 14.98% ROE reflect operational efficiency.
DOV presents a compelling investment case with 28% upside to the $243.20 consensus target. Strong cash flow generation and dividend consistency support shareholder returns, though technical weakness and competitive industrial markets pose near-term risks. The upcoming Q3 2026 earnings report on September 30 will be crucial for confirming growth trajectory.
HIMS stock trades at $28.06, down 5.01% on the day, amid a bearish technical signal and negative earnings surprises. The company reported a net loss of $142 million in 2026, with a negative net income margin of -5.51%, despite revenue growth to $2.6 billion. Multiple securities class action lawsuits filed in October 2026 create significant legal overhang, while analyst consensus remains mixed with a $32.17 price target but only 35% buy ratings.
The outlook is clouded by profitability challenges and legal risks, though revenue growth offers a potential catalyst if margins improve. Investors face substantial downside risk from ongoing litigation and weak earnings, offset by analyst price targets suggesting modest upside from current levels if operational execution improves.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Dover Corp
Dover is a diversified industrial manufacturing company with products and services that include digital printing for fast-moving consuming goods, marking and coding for the food and beverage industry, loaders for the waste collection industry, pumps for the transport of fluids, including petroleum and natural gas, and commercial refrigerators used in groceries and convenience stores. Most of the business operates in the United States. After the spinoff of Apergy, the company operates through five segments: engineered systems, clean energy and fueling solutions, imaging and identification, pumps and process solutions, and climate and sustainability technologies equipment.
Read more on DOV →About Hims and Hers Health Inc
Hims & Hers is a multi-specialty telehealth platform that provides personalized health and wellness products. It offers access to medical providers and treatments for hair loss, sexual health, and skincare.
Read more on HIMS →
